Sai Parenteral Limited IPO: GMP today, Price, Review, Detail
Sai Parenteral offers branded generic formulations and CDMO (Contract Development & Manufacturing Organisation) services covering injectables, tablets, capsules, liquid orals, and ointments across multiple therapeutic segments.
Sai Parenteral’s has filed DRHP to raise funds via IPO which comprises completely as Fresh issue of ₹ 285 Crore & Offer for Sale (OFS) of 3,500,000 equity shares.
